KLKe Lin

Ke Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ke Lin has a total of 75 co-authors. Here are the top co-authors by number of shared publications:

  • Weiqiang Ruan

    Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, People’s Republic of China

    12 shared publications
  • Guiying Zhang

    Research Center of Clinical Epidemiology and Evidence-Based Medicine, West China Hospital, Sichuan University, Chengdu, People’s Republic of China

    4 shared publications
  • Huizhen Liu

    Center of Biostatistics, Design, Measurement and Evaluation (CBDME), Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, People’s Republic of China

    4 shared publications
  • Lin Xie

    Sichuan University

    4 shared publications
  • Ting Wang

    Center of Biostatistics, Design, Measurement and Evaluation (CBDME), Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, People’s Republic of China

    4 shared publications
  • Xiaoqin Zhou

    Department of Vascular Surgery, West China Hospital, Sichuan University, Chengdu, People’s Republic of China

    4 shared publications

Latest Publications

  • Open Access

    Global Trends in Ischemic Heart Disease Mortality from 1990 to 2021 and 2036 Projections: Insights from GBD 2021 Data

    by Xiaoqin Zhou, Weiqiang Ruan, Hui Jie, Huizhen Liu, Ting Wang, Jing Li, Ke Lin, Jing Lin

    Background: Ischemic heart disease (IHD) remains a significant global health challenge despite advancements in prevention and treatment. This study aims to comprehensively analyze global IHD mortality trends from 1990 to 2021 and projections for 2036, to support evidence-based decision-making for IHD prevention and management strategies across diverse contexts. Methods: Using data from the Global Burden of Disease Study 2021, we conducted multi-level analyses of IHD mortality trends: globally, across socio-demographic index (SDI) quintiles, 21 Global Burden of Disease (GBD) regions, and 204 countries. We performed age-period-cohort (APC), decomposition, risk factor, and frontier analysis. Bayesian APC modeling was used for projections to 2036. Results: The global age-standardized mortality rate (ASMR) for IHD decreased from 1990 to 2021 (EAPC: –1.301%, net drift: –1.1%) despite a 67.5% increase in total deaths. APC analysis revealed exponential growth in IHD mortality rates with age, with the inflection point at 62.5 years in low SDI regions and 77.5 years in high SDI regions. High SDI regions demonstrated significant period and cohort effects. Frontier analysis showed that Nauru and Ukraine were the countries with the highest effective differences. Decomposition analysis identified population growth and aging as primary factors increasing IHD mortality. High systolic blood pressure remained the leading global risk factor, with increasing contributions from high fasting plasma glucose and high body-mass index, especially in high SDI regions. Projections indicate continued global ASMR decrease by 2036, but with concerning increases in Eastern Europe and some African regions. Conclusions: This study reveals the complex global landscape of IHD, emphasizing that high SDI regions should focus on comprehensive care for older adults and managing metabolic risk factors such as diabetes and obesity, while low and middle SDI regions need to strengthen healthcare systems and implement early prevention strategies. Regions projecting mortality increases require urgent attention and interventions. HIGHLIGHTS What is new? Global IHD age-standardized mortality rates decreased from 1990 to 2021 (EAPC: –1.301%, net drift: –1.1%), despite a 67.5% increase in total deaths, reflecting advancements in care and ongoing challenges of population aging and growth. APC analysis showed exponential growth in IHD mortality rates with age across all SDI regions, with low SDI regions’ inflection point 15 years earlier than high SDI regions, suggesting prioritization of comprehensive care for the elderly in high SDI areas. Decomposition analysis showed South Asia and East Asia experienced the largest increases in IHD deaths, with epidemiological changes contributing to death increases rather than reductions, underscoring the need for effective policies to address population growth and aging in these rapidly developing regions. High systolic blood pressure remains the leading global risk factor for IHD, with increasing contributions from high fasting plasma glucose and high body-mass index, especially in high SDI regions. Projections indicate continued global ASMR decrease by 2036, but with concerning increases in Eastern Europe and some African regions, particularly Southern Sub-Saharan Africa, necessitating targeted interventions. What are the clinical implications? High SDI regions should focus on comprehensive care for the elderly and managing metabolic risks like hypertension, diabetes, and obesity. Low and middle SDI regions need to strengthen healthcare systems and implement early prevention to combat rising IHD mortality. Regions with projected increases, such as Eastern Europe and Southern Sub-Saharan Africa, require urgent policy interventions and resource allocation to address disparities and improve preventive care access.


  • Open Access

    Feasibility of epicardial implantation of medtronic 3830 lead in a pediatric patient : case report

    by Dou Yuan, Ke Lin, Yuanning Xu

    Background: High-grade atrioventricular block is the primary reason for epicardial permanent pacemaker implantation during the perioperative period in patients with congenital heart disease. Due to the smaller diameter of venous vessels in children, epicardial permanent pacemaker implantation is usually a preferred choice, we report one pediatric patient who received epicardial permanent pacemaker implantation using a new approach. Case presentation: We present the case of a 2-year-old girl who underwent the modified Konno procedure and Pulmonary valvuloplasty surgery and presented after surgery with a High-grade atrioventricular block. At over 20 days after the patient underwent a redo-sternotomy which epicardial permanent pacemaker implantation. Medtronic Model 4965 Capsure Epi ® steroid-eluting unipolar epicardial pacing lead was immobilized on the surface of the right ear. The Medtronic 3830 pacing lead was screwed obliquely and clockwise under direct view from the surface of the right ventricle to the endocardium near the interventricular septum. The patient’s recovery was uneventful. Conclusion: In this case report, we demonstrate the feasibility and potential benefits of using the Medtronic 3830 lead for epicardial pacing in a pediatric patient with severe cardiac complications following surgery for congenital heart disease. This approach offers a viable alternative to traditional epicardial pacing methods, particularly in complex cases where conventional leads fail to provide stable pacing thresholds.


  • Open Access

    Assessing the causal relationship between circulating immune cells and abdominal aortic aneurysm by bi-directional Mendelian randomization analysis

    by Weiqiang Ruan, Xiaoqin Zhou, Ting Wang, Huizhen Liu, Guiying Zhang, Jiaoyan Sun, Ke Lin

    Although there is an association between abdominal aortic aneurysm (AAA) and circulating immune cell phenotypes, the exact causal relationship remains unclear. This study aimed to explore the causal relationships between immune cell phenotypes and AAA risk using a bidirectional two-sample Mendelian randomization approach. Data from genome-wide association studies pertaining to 731 immune cell traits and AAA were systematically analyzed. Using strict selection criteria, we identified 339 immune traits that are associated with at least 3 single nucleotide polymorphisms. A comprehensive MR analysis was conducted using several methods including Inverse Variance Weighted, Weighted Median Estimator, MR-Egger regression, Weighted Mode, and Simple Median methods. CD24 on switched memory cells (OR = 0.922, 95% CI 0.914–0.929, P = 2.62e−79) at the median fluorescence intensities level, and SSC-A on HLA-DR + natural killer cells (OR = 0.873, 95% CI 0.861–0.885, P = 8.96e−81) at the morphological parameter level, exhibited the strongest causal associations with AAA. In the reverse analysis, no significant causal effects of AAA on immune traits were found. The study elucidates the causal involvement of multiple circulating immune cell phenotypes in AAA development, signifying their potential as diagnostic markers or therapeutic targets. These identified immune traits may be crucial in modulating AAA-related inflammatory pathways.


  • Open Access

    Type 2 Diabetes Mellitus and Cardiovascular Health: Evidence of Causal Relationships in a European Ancestry Population

    by Weiqiang Ruan, Xiaoqin Zhou, Jing Li, Huizhen Liu, Ting Wang, Guiying Zhang, Ke Lin

    Aims: Type 2 diabetes mellitus (T2DM) is associated with increased cardiovascular disease (CVD) risk, but whether T2DM directly causes adverse cardiac remodelling is uncertain. We performed a comprehensive Mendelian randomization (MR) analysis to investigate the causal relevance of T2DM to CVD outcomes and cardiac structure/function. Methods and results: Bidirectional two-sample MR was conducted using summary-level data from European-ancestry genome-wide association studies. The T2DM GWAS data included 80 154 cases and 853 816 controls from the DIAGRAM consortium. Outcomes included coronary artery disease (CAD), myocardial infarction (MI), stroke, heart failure, atrial fibrillation, and various quantitative cardiac imaging traits assessed by magnetic resonance imaging. MR analysis revealed causal associations between genetic predisposition to T2DM and increased risk of CAD (odds ratio [OR] 1.104, 95% confidence interval [CI] 1.078–1.130, P = 2.59e-16), MI (OR 1.129, 95% CI 1.094–1.166, P = 6.02e-14) and stroke (OR 1.086, 95% CI 1.064–1.109, P = 1.02e-14). These associations were validated in the FinnGen cohort (CAD: OR 1.117, 95% CI 1.075–1.158, P = 1.56e-9; MI: OR 1.132, 95% CI 1.083–1.184, P = 4.27e-8; stroke: OR 1.138, 95% CI 1.107–1.170, P = 3.52e-20). Multivariable MR show consistent findings (CAD: OR 1.063, 95% CI 1.031–1.097, P = 1.11e-4; MI: OR 1.088, 95% CI 1.042–1.135, P = 1.12e-4; stroke: OR 1.066, 95% CI 1.032–1.101, P = 1.18e-4) after adjusting for cardiometabolic traits. T2DM was causally associated with higher left ventricular mass index (β = 0.473, 95% CI 0.193 to 0.752, P = 0.001), lower indexed right atrial minimum (β = −0.048, 95% CI −0.073 to −0.022, P = 2.1e-5), and maximum (β = −0.042, 95% CI −0.065 to −0.019, P = 4.12e-5) areas. The effects on right atrial size remained significant after adjusting for risk factors (minimum area: β = −0.041, 95% CI −0.072 to −0.010, P = 0.009; maximum area: β = −0.039, 95% CI −0.069 to −0.008, P = 0.012). Both apolipoprotein A1 and SBP are important mediators in the causal relationship between T2DM and left ventricular mass index. No reverse causal associations were identified. Conclusions: Our MR study demonstrates that genetic liability to T2DM plays causal roles in CAD, MI, stroke, and cardiac structure changes including left ventricular hypertrophy and reduced right atrial dimensions. These findings provide genetic evidence supporting glycaemic control in T2DM to mitigate cardiovascular complications and adverse cardiac remodelling.


  • Thyroid function effect on cardiac structure, cardiac function, and disease risk: Evidence of causal associations in European ancestry

    by Weiqiang Ruan, Xiaoqin Zhou, Jing Li, Ting Wang, Huizhen Liu, Guiying Zhang, Ke Lin


  • Causal role of circulating inflammatory cytokines in cardiac diseases, structure and function

    by Weiqiang Ruan, Xiaoqin Zhou, Huizhen Liu, Ting Wang, Guiying Zhang, Ke Lin


  • Open Access

    Causal Links Between Renal Function and Cardiac Structure, Function, and Disease Risk

    by Xiaoqin Zhou, Weiqiang Ruan, Lijun Zhao, Ke Lin, Jing Li, Huizhen Liu, Ting Wang, Guiying Zhang

    Background: Chronic kidney disease (CKD) increases the risk of adverse cardiovascular outcomes. However, the causal relationships between renal function and cardiovascular diseases (CVD) remain incompletely understood. This study aimed to determine the causal relationships between genetic susceptibility to impaired renal function and the risk of CVD endpoints, as well as cardiac structure and function detectable by cardiac magnetic resonance imaging (CMR). Methods: Bidirectional Mendelian randomization (MR) analyses were conducted using summary-level data from genome-wide association studies. The exposures were blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio (UACR), and CKD. The outcomes included atrial fibrillation, coronary artery disease (CAD), myocardial infarction, heart failure, stroke, and various CMR parameters. Sensitivity analyses, multivariable MR adjusting for cardiometabolic traits, and replication in the FinnGen cohort were performed. Results: Elevated BUN levels (OR 1.505; 95% CI 1.077 to 2.103; P = 0.017) were causally associated with increased CAD risk, but this relationship was attenuated after adjusting for cardiometabolic traits. Increased UACR was causally linked to higher risks of CAD (OR 1.260; 95% CI 1.042 to 1.523; P = 0.017), myocardial infarction (OR 1.424; 95% CI 1.137 to 1.783; P = 0.002), and stroke (OR 1.182; 95% CI 1.012 to 1.379; P = 0.035), with the association for stroke remaining significant after multivariable adjustment. Reduced eGFR was causally related to decreases in ascending aorta diameter, proximal pulmonary artery diameter, right atrial size, left ventricular stroke volume, and right ventricular volumes, even after accounting for potential confounders. CKD was causally associated with a reduced pulmonary artery-to-aorta ratio and proximal pulmonary artery diameter. Conclusions: This comprehensive MR study establishes causal roles of genetic susceptibility to impaired renal function influencing cardiovascular outcomes and cardiac structure.


  • Open Access

    A new approach for epicardial permanent pacemaker implantation in children: case report

    by Dou Yuan, Ke Lin, Yuanning Xu

    Background High-grade atrioventricular block is the primary reason for epicardial permanent pacemaker implantation during the perioperative period in patients with congenital heart disease. Due to the smaller diameter of venous vessels in children, epicardial permanent pacemaker implantation is usually a preferred choice, we report one pediatric patient who received epicardial permanent pacemaker implantation using a new approach. Case presentation We present the case of a 2-year-old girl who underwent the modified Konno procedure and Pulmonary valvuloplasty surgery and presented after surgery with a High-grade atrioventricular block. At over 20 days after the patient underwent a redo-sternotomy which epicardial permanent pacemaker implantation. Medtronic Model 4965 Capsure Epi ® steroid-eluting unipolar epicardial pacing lead was immobilized on the surface of the right ear. The Medtronic 3830 pacing lead was screwed obliquely and clockwise under direct view from the surface of the right ventricle to the endocardium near the interventricular septum. The patient’s recovery was uneventful. Conclusion A Medtronic 3830 pacing lead was screwed into the myocardium through the epicardium, which is a feasible approach for implanting the ventricular pacing electrode.

  • Open Access

    Three predictive models for transthoracic device closure of atrial septal defect: a comprehensive comparative analysis

    by Weiqiang Ruan, Junyang Han, Lin Xie, Ke Lin

    Background: Atrial Septal Defect (ASD) is a common congenital heart disease. Although transthoracic occlusion of ASD is increasingly seen as a less invasive alternative to traditional surgery, the choice of procedure often relies on the surgeon's experience and the insights gained from transesophageal echocardiography (TEE) images, lacking concrete, quantifiable standards. This study aims to guide clinical surgical decisions by developing and comparing predictive models. Methods: We analyzed 312 patients with secundum atrial septal defects who underwent either transthoracic device closure or open surgical repair. By measuring and analyzing preoperative TEE data and utilizing statistical and programming software, we developed three predictive models: logistic regression, random forest, and multiple linear regression. The original data were divided into a training dataset and a testing dataset, with each model trained on the training dataset and validated on the testing dataset. The predictive performance of each model was then evaluated on both adult and pediatric data. Results: Each model exhibited remarkable predictive power. The prediction accuracies in the training dataset for the logistic regression model, random forest model, and multiple linear regression model were 0.892, 0.888, and 0.868, respectively. In the testing dataset, the prediction accuracies were 0.9194, 0.871, and 0.9194, respectively. Conclusions: This study developed three predictive models to guide clinical surgical decisions for ASD closure surgery. Among them, the multivariate linear regression model demonstrated significant predictive accuracy, offering the potential to streamline the clinical decision-making process. This model does not require complex computations and is capable of providing quick, real-time predictions.